TACE Study-Liver Embolization Perfusion (VGH Radiology LIU)
NCT02093104 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2017-05-08
Summary
The purpose of this research study is to evaluate the quantitative information of utilizing C-arm systems in liver tumor care in hopes this potential clinical combination of imaging could aid in diagnosis and evaluation of tumor therapy.
Conditions
- Unresectable Hepatocellular Carcinoma
- Undergoing Chemoembolization and Radioembolization
Sponsors & Collaborators
-
University of British Columbia
lead OTHER
Principal Investigators
-
David MT Liu, MD · UBC/VCHA/VGH
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-02-28
- Primary Completion
- 2016-04-30
- Completion
- 2016-04-30
Countries
- Canada
Study Locations
More Related Trials
-
Prognostic Performance of Preoperative and Follow by Gadoxetic Enhanced MRI in HCC Patients After TACE
NCT05125094 ·Status: NOT_YET_RECRUITING
-
Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
NCT01326390 ·Status: TERMINATED
-
CT Volume Measurement of Hepatocellular Carcinoma
NCT07183566 ·Status: NOT_YET_RECRUITING
-
Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407)
NCT06483594 ·Status: NOT_YET_RECRUITING
-
Y-90 Treatment Response Using Transarterial Radioembolization
NCT07145801 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Post Y90 Liver Hypertrophy
NCT02783261 ·Status: UNKNOWN
-
Y90 Radioembolization Prior to Surgical Resection or Radiofrequency for Hepatocellular Carcinoma in Cirrhotic Liver
NCT01686880 ·Status: TERMINATED ·Phase: PHASE2
-
3T MRI to Predict TACE Response of HCC
NCT02070822 ·Status: UNKNOWN
-
Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography
NCT01360892 ·Status: UNKNOWN
-
Deep Learning-Based Multidimensional Body Composition Mapping for Outcome Prediction in HCC Patients Undergoing TACE
NCT07235410 ·Status: RECRUITING
-
Safety and Effectiveness of BioTraceIO Lite for Tissue Damage Assessment Following Liver Tissue Ablation Procedures
NCT04970212 ·Status: COMPLETED
-
Transient Elastography in Hepatectomy for Hepatocellular Carcinoma
NCT01441453 ·Status: UNKNOWN ·Phase: NA
-
CT-based HVPG Assessment for Predicting the Prognosis of HCC With TACE (CHANCE-CHESS 2302)
NCT05704192 ·Status: UNKNOWN
-
CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization
NCT03990623 ·Status: UNKNOWN ·Phase: NA
-
to Assess the Accuracy and Reliability of the Ga68-Dolacga Positron Emission Tomography Compared to Computer Tomography Volumetry and Indocyanine Green Retention Test for Measurement of Liver Reserve
NCT05007548 ·Status: COMPLETED ·Phase: PHASE2
-
Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies
NCT04258566 ·Status: TERMINATED ·Phase: NA
-
Prognosis Value of Non-invasive Methods for the Diagnosis of Chronic Liver Disease
NCT02060565 ·Status: RECRUITING
-
Perfusion and Dual Energy Computer Tomography in Hepatocellular Carcinoma
NCT03754192 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
NCT07295275 ·Status: RECRUITING
-
Predictive Model for Pain After TACE
NCT05545046 ·Status: COMPLETED
-
Role of (LMWH) in Prevention of Thromboembolic Complication After (TACE) in Hepatocellular Carcinoma.
NCT02715492 ·Status: UNKNOWN ·Phase: PHASE3
-
Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver Function
NCT03766555 ·Status: UNKNOWN ·Phase: NA
-
Pilot 3D Contrast-Enhanced Ultrasound Imaging to Predict Treatment Response in Liver Metastases
NCT01631318 ·Status: COMPLETED ·Phase: NA
-
Cohort Study of Patients With Hepatocellular Carcinoma and Circulating Tumor DNA Monitoring of Chemoembolization
NCT05390112 ·Status: UNKNOWN
-
Perfusion CT as a Predictor of Treatment Response in Patients With Hepatic Malignancies
NCT01163526 ·Status: TERMINATED